Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 36: 251-254, 1990;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molina, R.
Right arrow Articles by Balaque, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molina, R.
Right arrow Articles by Balaque, A.

Clinical Chemistry, Vol 36, 251-254, Copyright © 1990 by American Association for Clinical Chemistry

SCC antigen measured in malignant and nonmalignant diseases

R Molina, X Filella, MD Torres, AM Ballesta, P Mengual, A Cases and A Balaque
Laboratory of Clinical Biochemistry (Unit for Cancer Research), Hospital Clinico y Provincial, Medical School, Barcelona, Spain.

SCC antigen was measured in the serum of 214 patients with benign diseases and in 251 patients with various cancers. With 2.5 micrograms/L as the upper normal limit for serum, values were positive in 2.9% of 69 healthy subjects (I), 29.0% of 214 patients with benign pathologies (II), and 41% of 217 patients with active cancer (III). The highest values in group II were for patients in renal failure (64%) or with lung diseases (40%) or head-and-neck diseases (21.2%). Specificity of SCC increased (91.1%) when we excluded patients in renal failure or with creatinine values greater than 133 mumol/L. In group III, SCC values were abnormal in 57.7% of patients with squamous cell carcinoma, but in only 9.3% of those with other histological types (P less than 0.001). In squamous cell carcinoma of the lung, cervix, or head and neck, SCC values were related to tumor stage, values being highest in patients with metastases.


The following articles in journals at HighWire Press have cited this article:


Home page
 J. Histochem. Cytochem.Home page
S. Cataltepe, E. R. Gornstein, C. Schick, Y. Kamachi, K. Chatson, J. Fries, G. A. Silverman, and M. P. Upton
Co-expression of the Squamous Cell Carcinoma Antigens 1 and 2 in Normal Adult Human Tissues and Squamous Cell Carcinomas
J. Histochem. Cytochem., January 1, 2000; 48(1): 113 - 122.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
M.-H. Schlageter, J. Larghero, B. Cassinat, M.-E. Toubert, C. Borschneck, and J.-D. Rain
Serum Carcinoembryonic Antigen, Cancer Antigen 125, Cancer Antigen 15-3, Squamous Cell Carcinoma, and Tumor-associated Trypsin Inhibitor Concentrations during Healthy Pregnancy
Clin. Chem., September 1, 1998; 44(9): 1995 - 1998.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Association for Clinical Chemistry.